環球醫療(02666.HK)上半年營收75.81億元 純利同比增長8.0%至12.28億元
格隆匯8月27日丨環球醫療(02666.HK)公佈中期業績,2025年上半年,截至2025年6月30日止六個月,收入約人民幣7,580.7百萬元,較2024年同期的約人民幣6,542.7百萬元增長15.9%;公司普通股權益持有人應佔期內溢利約人民幣1,228.1百萬元,較2024年同期的約人民幣1,137.2百萬元增長8.0%。
於2025年6月30日,總資產約人民幣85,716.6百萬元,較於2024年12月31日的約人民幣86,032.3百萬元減少0.4%。於2025年6月30日,公司普通股權益持有人應佔權益約人民幣17,703.4百萬元,較於2024年12月31日的約人民幣17,175.7百萬元增長3.1%。截至2025年6月30日止六個月,股本回報率爲14.08%。截至2025年6月30日止六個月,總資產回報率爲3.11%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.